Intestinal liner holds promise for obesity, type 2 diabetes

09/18/2011 | InternalMedicineNews.com (free registration)

A small study presented at the European Society for the Study of Diabetes found that using a duodenal-jejunal bypass liner, an implantable weight-loss device, helped improve weight and blood glucose levels in obese patients with type 2 diabetes. The intestinal sleeve also increased the levels of incretin hormones glucagon-like peptide and peptide YY.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC